T J Steiner,M Tinelli
T J Steiner
Oguzhan Kursun,Muge Yemisci,Arn M J M van den Maagdenberg et al.
Oguzhan Kursun et al.
Background: Neuroinflammation has an important role in the pathophysiology of migraine, which is a complex neuro-glio-vascular disorder. The main aim of this review is to highlight findings of cortical spreading depolariz...
Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study [0.03%]
日本新冠肺炎疫情期间偏头痛患病情况调查——一项多中心横断面研究
Keisuke Suzuki,Takao Takeshima,Hisaka Igarashi et al.
Keisuke Suzuki et al.
Objectives: To assess the impacts of social situation changes due to the coronavirus disease 2019 (COVID-19) pandemic on headache-related disability and other symptoms in patients with migraine in Japan. ...
Multicenter Study
The journal of headache and pain. 2021 Jun 7;22(1):53. DOI:10.1186/s10194-021-01263-1 2021
The sensitivity to change of the cluster headache quality of life scale assessed before and after deep brain stimulation of the ventral tegmental area [0.03%]
用于测量延髓腹侧被盖区深部脑刺激前后丛集性头痛生命质量变化的敏感性
Davide Cappon,Agata Ryterska,Harith Akram et al.
Davide Cappon et al.
Background: Cluster headache (CH) is a trigeminal autonomic cephalalgia (TAC) characterized by a highly disabling headache that negatively impacts quality of life and causes limitations in daily functioning as well as soc...
Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients [0.03%]
一项针对104名患者的头痛和COVID-19患者与健康对照者细胞因子和细胞介素的病例对照研究
Javier Trigo,David García-Azorín,Álvaro Sierra-Mencía et al.
Javier Trigo et al.
Background: The presence of headache during the acute phase of COVID-19 could be associated with the innate response and the cytokine release. We aim to compare the cytokine and interleukin profile in hospitalized COVID-1...
Observational Study
The journal of headache and pain. 2021 Jun 4;22(1):51. DOI:10.1186/s10194-021-01268-w 2021
Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study [0.03%]
长效肉毒杆菌毒素治疗慢性偏头痛可减少医疗资源的使用：一项真实世界研究
Katja Kollewe,Charly Gaul,Astrid Gendolla et al.
Katja Kollewe et al.
Background: Chronic migraine (CM) is associated with substantial economic burden. Real-world data suggests that onabotulinumtoxinA treatment for CM reduces healthcare resource utilisation (HRU) and related costs. ...
Observational Study
The journal of headache and pain. 2021 Jun 2;22(1):50. DOI:10.1186/s10194-021-01260-4 2021
The prevalence and burden of recurrent headache in Australian adolescents: findings from the longitudinal study of Australian children [0.03%]
澳大利亚儿童纵向研究中青少年反复头痛的流行率和疾病负担
Margot J Wilkes,M Dilani Mendis,Leanne Bisset et al.
Margot J Wilkes et al.
Background: Headache disorders are highly prevalent worldwide, but not well investigated in adolescents. Few studies have included representative nationwide samples. This study aimed to present the prevalence and burden o...
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials [0.03%]
抗CGRP抗体Galcanezumab治疗患者的偏头痛类型从高频次转变为低频次：来自两项全球范围内随机临床试验的结果分析
Jakub Jedynak,Eric Eross,Astrid Gendolla et al.
Jakub Jedynak et al.
Background: Patients with episodic migraine (EM) with a higher-frequency of migraine headache days (HFEM: 8-14 migraine headache days/month) have a greater disease burden and a higher risk of progressing to chronic migrai...
Randomized Controlled Trial
The journal of headache and pain. 2021 May 28;22(1):48. DOI:10.1186/s10194-021-01222-w 2021
Activation of CamKIIα expressing neurons on ventrolateral periaqueductal gray improves behavioral hypersensitivity and thalamic discharge in a trigeminal neuralgia rat model [0.03%]
活化伏外侧periaqueductal灰质CamKIIα阳性神经元改善三叉神经痛大鼠模型的行为过敏和丘脑放电
K C Elina,Byeong Ho Oh,Jaisan Islam et al.
K C Elina et al.
Background: Preceding studies have reported the association of chronic neuropathic orofacial pain with altered ongoing function in the ventrolateral periaqueductal gray (vlPAG). However, its role in trigeminal neuralgia (...
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials [0.03%]
对：偏头痛患者皮下注射Eptinezumab的耐受性和安全性：五项临床试验结果的汇总分析纠正说明
Timothy R Smith,Egilius L H Spierings,Roger Cady et al.
Timothy R Smith et al.
Published Erratum
The journal of headache and pain. 2021 May 25;22(1):46. DOI:10.1186/s10194-021-01253-3 2021